Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Leprosy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the efficacy and safety of bedaquiline (TMC207) in participants with multibacillary leprosy, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy
• Multibacillary Leprosy

Drugs mentioned

• bedaquiline (bedaquiline)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Leprosy, Multibacillary | Phase 2 | Status: COMPLETED